Sara Secall
Partner & Life Sciences Investment Director, Inveready Asset Management
Sara is responsible for building a portfolio of exciting biomedical and health companies at Inveready. She has launched and financed over 25 technology-based companies, and successfully exited several projects with strong VC returns. Since 2001, she has worked in venture capital both in Silicon Valley and in Spain, with technology transfer offices at various universities, and served as an independent expert for the European Commission. She has also consulted in environmental sciences for both Dames and Moore (now URS Corp), the International Finance Corporation, and the World Bank in the US, Canada and Latin America.
Sara received her MBA at London Business School, and holds a Master in Sciences from Indiana University Bloomington and a Bachelor of Science in Chemistry from the Universitat de Barcelona.
